{
    "root": "64a65366-8577-48f2-9f8e-0332f126d3c1",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Gabapentin",
    "value": "20250301",
    "ingredients": [
        {
            "name": "GABAPENTIN",
            "code": "6CW7F3G59X"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M"
        },
        {
            "name": "BUTYL ALCOHOL",
            "code": "8PJ61P6TS3"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X"
        },
        {
            "name": "FD&C BLUE NO. 1 ALUMINUM LAKE",
            "code": "J9EQA3S2JM"
        },
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        }
    ],
    "indications": "gabapentin capsules indicated : \u2022management postherpetic neuralgia adults \u2022adjunctive therapy treatment partial onset seizures , without secondary generalization , adults pediatric patients 3 years older epilepsy",
    "contraindications": "\u2022 postherpetic neuralgia ( 2.1 ) \u2022 dose titrated needed dose 1,800 mg/day \u2022 day 1 : single 300 mg dose \u2022 day 2 : 600 mg/day ( i.e . , 300 mg two times day ) \u2022 day 3 : 900 mg/day ( i.e . , 300 mg three times day ) \u2022 epilepsy partial onset seizures ( 2.2 ) \u2022 patients 12 years age older : starting dose 300 mg three times daily ; may titrated 600 mg three times daily \u2022 patients 3 11 years age : starting dose range 10 15 mg/kg/day , given three divided doses ; recommended dose patients 3 4 years age 40 mg/kg/day , given three divided doses ; recommended dose patients 5 11 years age 25 35 mg/kg/day , given three divided doses . recommended dose reached upward titration period approximately 3 days \u2022 dose adjusted patients reduced renal function ( 2.3 , 2.4 )",
    "warningsAndPrecautions": "gabapentin capsules , usp available containing 300 mg gabapentin , usp , supplied follows : 300 mg capsules : size ' 1 ' hard gelatin capsules yellow opaque cap yellow opaque body , imprinted `` 300 mg `` blue ink cap `` 235 `` blue ink body , filled white off-white powder . capsules supplied bottles : bottles 90 capsules ndc 82804-206-90 storage store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) ; [ usp controlled room temperature ] .",
    "adverseReactions": "gabapentin capsules contraindicated patients demonstrated hypersensitivity ingredients .",
    "indications_original": "Gabapentin Capsules are indicated for: \n                  \n                     \n                        \u2022Management of postherpetic neuralgia in adults\n                     \n                        \u2022Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy",
    "contraindications_original": "\u2022 Postherpetic Neuralgia (2.1) \u2022 Dose can be titrated up as needed to a dose of 1,800 mg/day \u2022 Day 1: Single 300 mg dose \u2022 Day 2: 600 mg/day (i.e., 300 mg two times a day) \u2022 Day 3: 900 mg/day (i.e., 300 mg three times a day) \u2022 Epilepsy with Partial Onset Seizures (2.2) \u2022 Patients 12 years of age and older: starting dose is 300 mg three times daily; may be titrated up to 600 mg three times daily \u2022 Patients 3 to 11 years of age: starting dose range is 10 to 15 mg/kg/day, given in three divided doses; recommended dose in patients 3 to 4 years of age is 40 mg/kg/day, given in three divided doses; the recommended dose in patients 5 to 11 years of age is 25 to 35 mg/kg/day, given in three divided doses. The recommended dose is reached by upward titration over a period of approximately 3 days \u2022 Dose should be adjusted in patients with reduced renal function (2.3, 2.4)",
    "warningsAndPrecautions_original": "Gabapentin Capsules, USP are available containing 300 mg of gabapentin, USP, supplied as follows:\u00a0\u00a0\u00a0\u00a0\n                  300 mg capsules:\n                  Size '1' Hard gelatin capsules with yellow opaque cap and yellow opaque body, imprinted \"300 mg\" in blue ink on cap and \"235\" in blue ink on body, filled with white to off-white powder.\n                  Capsules are supplied in bottles of:\n                  Bottles of 90 Capsules \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 82804-206-90\n                  \n                     Storage\n                  \n                  Store at 20\u00b0C to 25\u00b0C (68\u00b0F to 77\u00b0F); [see USP Controlled Room Temperature].",
    "adverseReactions_original": "Gabapentin capsules are contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients."
}